Literature DB >> 1671716

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.

G R Flentke1, E Munoz, B T Huber, A G Plaut, C A Kettner, W W Bachovchin.   

Abstract

Dipeptidyl peptidase IV (DP-IV; dipeptidyl-peptide hydrolase, EC 3.4.14.5) is a serine protease with a specificity for cleaving Xaa-Pro dipeptides from polypeptides and proteins. It is found in a variety of mammalian cells and tissues, including those of lymphoid origin where it is found specifically on the surface of CD4+ T cells. Although the functional significance of this enzyme has not been established, a role in T-cell activation and immune regulation has been proposed. Here we report that Ala-boroPro and Pro-boroPro, where boroPro is the alpha-amino boronic acid analog of proline, are potent and specific inhibitors of DP-IV, having Ki values in the nanomolar range. Blocking the N terminus of Ala-boroPro abolishes the affinity of this inhibitor for DP-IV, while removal of the N-terminal residue, to give boroPro, reduces the affinity for DP-IV by 5 orders of magnitude. The dipeptide boronic acids exhibit slow-binding kinetics, while boroPro does not. We also report here that low concentrations of Pro-boroPro inhibit antigen-induced proliferation and interleukin 2 production in murine T-cell lines but do not inhibit the response of these T cells to the mitogen concanavalin A. These results indicate that DP-IV plays a role in antigen-induced, but not mitogen-induced, activation of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671716      PMCID: PMC51058          DOI: 10.1073/pnas.88.4.1556

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane. Purification by immunoadsorbent chromatography and some properties.

Authors:  B Svensson; M Danielsen; M Staun; L Jeppesen; O Norén; H Sjöström
Journal:  Eur J Biochem       Date:  1978-10-16

2.  A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics.

Authors:  V K Hopsu-Havu; P Rintola; G G Glenner
Journal:  Acta Chem Scand       Date:  1968

3.  [Kinetics of dipeptidyl-peptidase IV].

Authors:  B Wolf; G Fischer; A Barth
Journal:  Acta Biol Med Ger       Date:  1978

4.  Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV.

Authors:  E Schön; H U Demuth; E Eichmann; H J Horst; I J Körner; J Kopp; T Mattern; K Neubert; F Noll; A J Ulmer
Journal:  Scand J Immunol       Date:  1989-02       Impact factor: 3.487

5.  Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.

Authors:  L A Frohman; T R Downs; E P Heimer; A M Felix
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Enzymehistochemical staining of T mu lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV).

Authors:  A C Feller; C J Heijnen; R E Ballieux; M R Parwaresch
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

7.  Stepwise cleavage of the pro part of promelittin by dipeptidylpeptidase IV. Evidence for a new type of precursor--product conversion.

Authors:  G Kreil; L Haiml; G Suchanek
Journal:  Eur J Biochem       Date:  1980-10

8.  A novel location for dipeptidyl aminopeptidase processing sites in the alkaline extracellular protease of Yarrowia lipolytica.

Authors:  S Matoba; D M Ogrydziak
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids.

Authors:  C A Kettner; R Bone; D A Agard; W W Bachovchin
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

10.  Isolation and characterization of dipeptidyl peptidase IV from human placenta.

Authors:  G Püschel; R Mentlein; E Heymann
Journal:  Eur J Biochem       Date:  1982-08
View more
  31 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Differential expression of two distinct forms of mRNA encoding members of a dipeptidyl aminopeptidase family.

Authors:  K Wada; N Yokotani; C Hunter; K Doi; R J Wenthold; S Shimasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Authors:  William H Peranteau; Masayuki Endo; Obinna O Adibe; Aziz Merchant; Philip W Zoltick; Alan W Flake
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

4.  Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1.

Authors:  He Meng; Subrahmanian Tarakkad Krishnaji; Martin Beinborn; Krishna Kumar
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

5.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  CD26 induces T-cell proliferation by tyrosine protein phosphorylation.

Authors:  E Muñoz; M V Blazquez; J A Madueño; G Rubio; J Peña
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

8.  Involvement of dipeptidyl peptidase IV in an in vivo immune response.

Authors:  T Kubota; G R Flentke; W W Bachovchin; B D Stollar
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

9.  Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.

Authors:  U Aytac; K Sato; T Yamochi; T Yamochi; K Ohnuma; G B Mills; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

10.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.